Pazopanib/Doxil in Adv Relapsed Plat Sensitive or Resistant Ovarian, Fallopian or Primary Peritoneal Adenocarcinoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Fallopian Tube Cancer
Related studies linked through entity extraction aliases.
Study of RAD001 and Bevacizumab in Recurrent Ovarian, Peritoneal, and Fallopian Tube Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Intraperitoneal vs Intravenous Chemotherapy Following Neoadjuvant Chemotherapy in Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Belinostat and Carboplatin in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Carboplatin or Cisplatin
- Status
- COMPLETED
- Phase
- PHASE2
Study of Paclitaxel in Patients With Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Positron Emission Tomography/Computed Tomography (PET/CT) in Relapsed Ovarian Cancer (MK-0000-143)
- Status
- COMPLETED
- Phase
- PHASE1
Vorinostat, Carboplatin and Gemcitabine in Women With Recurrent, Platinum-Sensitive Ovarian Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Nutritional Supplements in Improving Quality of Life During First-Line Chemotherapy in Patients With Metastatic Gynecological Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Lenalidomide and Doxorubicin Hydrochloride Liposome in Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Laboratory Study in Predicting Tumor Response to Chemotherapy in Patients With Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
- Status
- UNKNOWN
- Phase
- N/A
S0904: Docetaxel With or Without Vandetanib in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Outcomes From Home in Patients Recovering From Major Gynecologic Cancer Surgery: Measuring Symptoms and Health-related Quality of Life
- Status
- COMPLETED
- Phase
- N/A
Avastin in Patients With Epithelial Ovarian, Primary Peritoneal Serous or Fallopian Tube Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Sequential Angiogenic Blockade for the Treatment of Recurrent Mullerian Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
Early Post-Operative Enteral Feeding in Patients With Advanced Epithelial Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Topotecan in Treating Patients With Gynecologic Cancer That Cannot Be Removed by Surgery
- Status
- COMPLETED
- Phase
- PHASE1
Two Different Schedules of Carboplatin, Paclitaxel, Gemcitabine, and Surgery in Treating Patients With Newly Diagnosed Stage IIIC or Stage IV Primary Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Vaccine Therapy in Stage II, III, or IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancers
- Status
- COMPLETED
- Phase
- PHASE1
Primary Tumor Harvest for the Purpose of Possible Use in a Future Clinical Trial in Patients With Ovarian, Fallopian Tube or Primary Peritoneal Cancer
- Status
- COMPLETED
- Phase
- NA
Vaccination of Patients With Ovarian Cancer With Dendritic Cell/Tumor Fusions With Granulocyte Macrophage Colony-stimulating Factor (GM-CSF) and Imiquimod
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2